Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2017
Purpose: Regulation FD Disclosure to furnish an investor presentation (Exhibit 99.1) intended for use in meetings with investors or analysts.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of an investor presentation and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document references an attached presentation for further details but does not summarize comparative period data within the 8-K text itself.
Guidance, Outlook, and Risks
Management Commentary: The company is providing an investor presentation dated January 2017.
Legal Disclaimer: The information furnished in this report and its exhibits is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the investor presentation attached as Exhibit 99.1 for specific financial guidance or operational updates.
- Note that the information in this 8-K is not legally "filed" for liability purposes under Section 18 of the Exchange Act.
- Confirm the date of the presentation (January 2017) to ensure data currency relative to current market conditions.